SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,283 | +10.0% | 30,567 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,166 | -99.5% | 30,567 | +398.9% | 0.00% | +200.0% |
Q3 2022 | $240,000 | +18.2% | 6,127 | 0.0% | 0.00% | – |
Q1 2022 | $203,000 | -89.9% | 6,127 | -87.0% | 0.00% | -100.0% |
Q4 2021 | $2,005,000 | +34.7% | 47,139 | +137.1% | 0.00% | +33.3% |
Q1 2021 | $1,488,000 | -54.1% | 19,883 | -47.0% | 0.00% | -62.5% |
Q4 2020 | $3,244,000 | +10.1% | 37,505 | -22.2% | 0.01% | 0.0% |
Q3 2020 | $2,947,000 | +44.2% | 48,226 | -1.9% | 0.01% | +33.3% |
Q2 2020 | $2,044,000 | +45.2% | 49,154 | +0.3% | 0.01% | +20.0% |
Q1 2020 | $1,408,000 | -71.1% | 49,023 | -27.5% | 0.01% | -64.3% |
Q4 2019 | $4,878,000 | -42.3% | 67,579 | +12.0% | 0.01% | -46.2% |
Q3 2019 | $8,461,000 | -21.4% | 60,314 | +2.6% | 0.03% | -21.2% |
Q2 2019 | $10,761,000 | +15.8% | 58,772 | +0.6% | 0.03% | +13.8% |
Q1 2019 | $9,295,000 | +67.7% | 58,439 | +1.0% | 0.03% | +45.0% |
Q4 2018 | $5,543,000 | +105.3% | 57,863 | +202.7% | 0.02% | +150.0% |
Q3 2018 | $2,700,000 | -19.5% | 19,118 | -10.8% | 0.01% | -27.3% |
Q2 2018 | $3,355,000 | -2.3% | 21,437 | +0.5% | 0.01% | -8.3% |
Q1 2018 | $3,434,000 | -1.0% | 21,322 | +1.3% | 0.01% | 0.0% |
Q4 2017 | $3,467,000 | – | 21,050 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |